|
 |
|
|||||||
|
|||||||||
Correspondence to:
Shun Ishibashi
Lipoprotein lipase (LPL) is known to play a crucial role in lipoprotein metabolism by hydrolyzing triglycerides; however its role in atherogenesis has yet to be determined. We have previously shown that low density lipoprotein receptor knockout mice overexpressing LPL are resistant to diet-induced atherosclerosis due to the suppression of remnant lipoproteins. Plasma lipoproteins and atherosclerosis of apolipoprotein (apo) E knockout mice which overexpress the human LPL transgene (LPL/APOEKO) were compared with those of control apoE knockout mice (APOEKO). On a normal chow diet, LPL/APOEKO mice showed marked suppression of the plasma triglyceride levels compared with APOEKO mice (54 vs. 182 mg/dl), but no significant changes in plasma cholesterol and apoB levels. Non-high density lipoproteins (HDL) from LPL/APOEKO mice had lower triglyceride content, a smaller size, and a more positive charge compared with those from APOEKO mice. Cholesterol, apoA-I, and apoA-IV were increased in HDL. Although both groups developed hypercholesterolemia to a comparable degree in response to an atherogenic diet, the LPL/APOEKO mice developed 2-fold smaller fatty streak lesions in the aortic sinus compared to the APOEKO mice.
In conclusion, overproduction of LPL is protective against atherosclerosis even in the absence of apoE.—Yagyu, H., S. Ishibashi, Z. Chen, J. Osuga, M. Okazaki, S. Perrey, T. Kitamine, M. Shimada, K. Ohashi, K. Harada, F. Shionoiri, N. Yahagi, T. Gotoda, Y. Yazaki, and N. Yamada. Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice. J. Lipid Res. 1999. 40: 1677;–1685.
Supplementary key words:
lipoprotein lipase, apolipoprotein E, knockout mice, atherosclerosis, triglycerides, cholesterol, foam cells, remnant lipoproteins, apolipoprotein A-I, apolipoprotein A-IV
Copyright © 1999 by Lipid Research, Inc.
Original Article
Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice
Hiroaki Yagyua,
Shun Ishibashia,
Zhong Chena,
Jun-ichi Osugaa,
Mitsuyo Okazakib,
Stéphane Perreya,
Tetsuya Kitaminea,
Masako Shimadaa,
Ken Ohashia,
Kenji Haradaa,
Futoshi Shionoiria,
Naoya Yahagia,
Takanari Gotodaa,
Yoshio Yazakia, and
Nobuhiro Yamadaa
a Department of Internal Medicine, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113, Japan
b Laboratory of Chemistry, Department of General Education, Tokyo Medical and Dental University, Chiba, Japan
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Sumiyoshi, H. Mokuno, T. Iesaki, K. Shimada, T. Miyazaki, A. Kume, T. Kiyanagi, K. Kuremoto, Y. Watanabe, N. Tada, et al. Deletion of the Fc receptors {gamma} chain preserves endothelial function affected by hypercholesterolaemia in mice fed on a high-fat diet Cardiovasc Res, December 1, 2008; 80(3): 463 - 470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Qiu and J. S. Hill Endothelial lipase enhances low density lipoprotein binding and cell association in THP-1 macrophages Cardiovasc Res, December 1, 2007; 76(3): 528 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Fujiwara, N. Kiyota, M. Hori, S. Matsushita, Y. Iijima, K. Aoki, D. Shibata, M. Takeya, T. Ikeda, T. Nohara, et al. Esculeogenin A, a New Tomato Sapogenol, Ameliorates Hyperlipidemia and Atherosclerosis in ApoE-Deficient Mice by Inhibiting ACAT Arterioscler Thromb Vasc Biol, November 1, 2007; 27(11): 2400 - 2406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wang, W. Jin, and D. J. Rader Upregulation of Macrophage Endothelial Lipase by Toll-Like Receptors 4 and 3 Modulates Macrophage Interleukin-10 and -12 Production Circ. Res., April 13, 2007; 100(7): 1008 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Zschenker, T. Illies, and D. Ameis Overexpression of lysosomal Acid lipase and other proteins in atherosclerosis. J. Biochem., July 1, 2006; 140(1): 23 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rip, M. C. Nierman, N. J. Wareham, R. Luben, S. A. Bingham, N. E. Day, J. N.I. van Miert, B. A. Hutten, J. J.P. Kastelein, J. A. Kuivenhoven, et al. Serum Lipoprotein Lipase Concentration and Risk for Future Coronary Artery Disease: The EPIC-Norfolk Prospective Population Study Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): 637 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-a. Kawashiri, T. Higashikata, M. Mizuno, M. Takata, S. Katsuda, K. Miwa, T. Nozue, A. Nohara, A. Inazu, J. Kobayashi, et al. Long-Term Course of Lipoprotein Lipase (LPL) Deficiency Due to Homozygous LPLArita in a Patient with Recurrent Pancreatitis, Retained Glucose Tolerance, and Atherosclerosis J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6541 - 6544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Kota, C. V. Ramana, F. A. Tenorio, R. I. Enelow, and J. C. Rutledge Differential Effects of Lipoprotein Lipase on Tumor Necrosis Factor-{alpha} and Interferon-{gamma}-mediated Gene Expression in Human Endothelial Cells J. Biol. Chem., September 2, 2005; 280(35): 31076 - 31084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Koike, J. Liang, X. Wang, T. Ichikawa, M. Shiomi, H. Sun, T. Watanabe, G. Liu, and J. Fan Enhanced aortic atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits expressing lipoprotein lipase Cardiovasc Res, February 1, 2005; 65(2): 524 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sata, H. Nishimatsu, J.-i. Osuga, K. Tanaka, N. Ishizaka, S. Ishibashi, Y. Hirata, and R. Nagai Statins Augment Collateral Growth in Response to Ischemia but They Do Not Promote Cancer and Atherosclerosis Hypertension, June 1, 2004; 43(6): 1214 - 1220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Koike, J. Liang, X. Wang, T. Ichikawa, M. Shiomi, G. Liu, H. Sun, S. Kitajima, M. Morimoto, T. Watanabe, et al. Overexpression of Lipoprotein Lipase in Transgenic Watanabe Heritable Hyperlipidemic Rabbits Improves Hyperlipidemia and Obesity J. Biol. Chem., February 27, 2004; 279(9): 7521 - 7529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ricote, A. F. Valledor, and C. K. Glass Decoding Transcriptional Programs Regulated by PPARs and LXRs in the Macrophage: Effects on Lipid Homeostasis, Inflammation, and Atherosclerosis Arterioscler Thromb Vasc Biol, February 1, 2004; 24(2): 230 - 239. [Abstract] [Full Text]
|
|
|
|
 |
|
 I. Namatame, H. Tomoda, S. Ishibashi, and S. Omura Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages PNAS, January 20, 2004; 101(3): 737 - 742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Tontonoz and D. J. Mangelsdorf Liver X Receptor Signaling Pathways in Cardiovascular Disease Mol. Endocrinol., June 1, 2003; 17(6): 985 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ando, T. Shimizugawa, S. Takeshita, M. Ono, M. Shimamura, R. Koishi, and H. Furukawa A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice J. Lipid Res., June 1, 2003; 44(6): 1216 - 1223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Ziouzenkova, S. Perrey, L. Asatryan, J. Hwang, K. L. MacNaul, D. E. Moller, D. J. Rader, A. Sevanian, R. Zechner, G. Hoefler, et al. Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: Evidence for an antiinflammatory role for lipoprotein lipase PNAS, March 4, 2003; 100(5): 2730 - 2735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Imai, T. Shindo, K. Maemura, M. Sata, Y. Saito, Y. Kurihara, M. Akishita, J. Osuga, S. Ishibashi, K. Tobe, et al. Resistance to Neointimal Hyperplasia and Fatty Streak Formation in Mice With Adrenomedullin Overexpression Arterioscler Thromb Vasc Biol, August 1, 2002; 22(8): 1310 - 1315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R Mead and D. P Ramji The pivotal role of lipoprotein lipase in atherosclerosis Cardiovasc Res, August 1, 2002; 55(2): 261 - 269. [Full Text] [PDF]
|
|
|
|
|
|
S. Usui, Y. Hara, S. Hosaki, and M. Okazaki A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC J. Lipid Res., May 1, 2002; 43(5): 805 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. O. Pentikainen, R. Oksjoki, K. Oorni, and P. T. Kovanen Lipoprotein Lipase in the Arterial Wall: Linking LDL to the Arterial Extracellular Matrix and Much More Arterioscler Thromb Vasc Biol, February 1, 2002; 22(2): 211 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Fan, H. Unoki, N. Kojima, H. Sun, H. Shimoyamada, H. Deng, M. Okazaki, H. Shikama, N. Yamada, and T. Watanabe Overexpression of Lipoprotein Lipase in Transgenic Rabbits Inhibits Diet-induced Hypercholesterolemia and Atherosclerosis J. Biol. Chem., October 19, 2001; 276(43): 40071 - 40079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Chen, S. Ishibashi, S. Perrey, J.-i. Osuga, T. Gotoda, T. Kitamine, Y. Tamura, H. Okazaki, N. Yahagi, Y. Iizuka, et al. Troglitazone Inhibits Atherosclerosis in Apolipoprotein E-Knockout Mice : Pleiotropic Effects on CD36 Expression and HDL Arterioscler Thromb Vasc Biol, March 1, 2001; 21(3): 372 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Stamler, D. Breznan, T. A-M. Neville, F. J. Viau, E. Camlioglu, and D. L. Sparks Phosphatidylinositol promotes cholesterol transport in vivo J. Lipid Res., August 1, 2000; 41(8): 1214 - 1221. [Abstract] [Full Text]
|
|
|
|
|
|
S. M. Clee, N. Bissada, F. Miao, L. Miao, A. D. Marais, H. E. Henderson, P. Steures, J. McManus, B. McManus, R. C. LeBoeuf, et al. Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis J. Lipid Res., April 1, 2000; 41(4): 521 - 531. [Abstract] [Full Text]
|
|
|
|
|
|
M. O. Pentikainen, K. Oorni, and P. T. Kovanen Lipoprotein Lipase (LPL) Strongly Links Native and Oxidized Low Density Lipoprotein Particles to Decorin-coated Collagen. ROLES FOR BOTH DIMERIC AND MONOMERIC FORMS OF LPL J. Biol. Chem., February 25, 2000; 275(8): 5694 - 5701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Usui, M. Nakamura, K. Jitsukata, M. Nara, S. Hosaki, and M. Okazaki Assessment of Between-Instrument Variations in a HPLC Method for Serum Lipoproteins and Its Traceability to Reference Methods for Total Cholesterol and HDL-Cholesterol Clin. Chem., January 1, 2000; 46(1): 63 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yagyu, T. Kitamine, J.-i. Osuga, R.-i. Tozawa, Z. Chen, Y. Kaji, T. Oka, S. Perrey, Y. Tamura, K. Ohashi, et al. Absence of ACAT-1 Attenuates Atherosclerosis but Causes Dry Eye and Cutaneous Xanthomatosis in Mice with Congenital Hyperlipidemia J. Biol. Chem., July 7, 2000; 275(28): 21324 - 21330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Hasty, H. Shimano, J.-i. Osuga, I. Namatame, A. Takahashi, N. Yahagi, S. Perrey, Y. Iizuka, Y. Tamura, M. Amemiya-Kudo, et al. Severe Hypercholesterolemia, Hypertriglyceridemia, and Atherosclerosis in Mice Lacking Both Leptin and the Low Density Lipoprotein Receptor J. Biol. Chem., September 28, 2001; 276(40): 37402 - 37408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-i. Tozawa, S. Ishibashi, J.-i. Osuga, K. Yamamoto, H. Yagyu, K. Ohashi, Y. Tamura, N. Yahagi, Y. Iizuka, H. Okazaki, et al. Asialoglycoprotein Receptor Deficiency in Mice Lacking the Major Receptor Subunit. ITS OBLIGATE REQUIREMENT FOR THE STABLE EXPRESSION OF OLIGOMERIC RECEPTOR J. Biol. Chem., April 13, 2001; 276(16): 12624 - 12628. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |